Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Danzhen in the Preventive Treatment of Migraine:A Prospective "Real-World" Study.

NCT02645370 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT02645370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02645370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Danzhen in the Preventive Treatment of Migraine:A Prospective "Real-World" Study.
Lead sponsor
Xijing Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
February 29, 2016
Completion date
Not reported
Enrollment
3,300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine